🔎 Trials Near Me

Home › Myasthenia Gravis › Wisconsin

Myasthenia Gravis clinical trials in Wisconsin

7 studies for Myasthenia Gravis are looking for participants at sites in Wisconsin.

Cities in Wisconsin

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1035, Greenfield
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  • Mg0038 10108, Greenfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07463521

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, Milwaukee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06680037

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  • BCN Research, Greenfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT06463587

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Milwaukee
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

  • BCN Research, LLC - Gamma Therapeutic Center, Greenfield
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06298565

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

  • Brain Inflammation Collaborative, Delafield
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.